Novavax Inc (WBO:NVAX)
€ 9.276 -0.09 (-0.96%) Market Cap: 1.49 Bil Enterprise Value: 734.28 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 47/100

Novavax Inc at H C Wainwright Global Investment Conference (Virtual)Panel- Pre-Recorded Transcript

Sep 15, 2021 / 04:00PM GMT
Michael Evan Meyers
H.C. Wainwright & Co., LLC - Vice Chairman, Head of M&A and Strategic Advisory Services

Welcome to our panelists, corporate and investment clients. I'm Michael Meyers, Vice Chair and Head of M&A and Strategic Advisory Services with H.C. Wainwright. And on behalf of John Chambers, our President and Head of Investment Banking and all of our Wainwright colleagues, it is my pleasure to welcome you and wish you a productive last day of the Global Investment Conference.

I hope that you have found the content and evening events both educational and enjoyable to include company presentations, one-on-ones, our fireside chat with Scott Gottlieb and clinical trials panel, our virtual cooking together and tour and tasting of Far Niente last night.

With that, I would now like to introduce our moderator and facilitator of our Best Practices Planning for the Next Pandemic panel, Dr. Scott Gottlieb. Scott is a physician and an investor who served as the 23rd Commissioner of Food and Drugs. Scott continues to be a leading voice of timely information in respect of our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot